Transcend CLL 004 Update #ASH19 @cityofhope

Transcend CLL 004 Update #ASH19 @cityofhope

ash

1 month
9 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:

Tanya Siddiqi, MD of @cityofhope discusses the updated results from transcend CLL 004, a Phase 1/2 study including patients with high-risk disease treated with ibrutinib.

Up Next Autoplay